HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
1 - 3 of 3
Canagliflozin in Children with Type 2 Diabetes
The goal of this study is to investigate the efficacy and safety of Canagliflozin (which is experimental) in children and adolescents ages 10 to 18 years old with Type 2 diabetes and poor control (i.e., an HbA1c of 6.5% to 10.5%).
Related PI: Lorraine L. Katz, MD
Related Conditions: Diabetes, Type 2 Diabetes, Diabetes Mellitus
Ertugliflozin for Children and Adolescents with Type 2 Diabetes
You are invited to take part in a voluntary research trial because you have type 2 diabetes and are between the ages of 10 and 17 years.
Related PI: Steven M. Willi, MD
Related Conditions: Type 2 Diabetes, Diabetes, Diabetes Mellitus
The Charisma Study
We are currently enrolling adolescents ages 15-21 of South Asian ancestry, African American ancestry, and European American or "White" ancestry.
Related PI: Andrea Kelly, MD, MSCE
Related Conditions: Diabetes, Heart Disease, Cardiovascular Diseases